Tag: global pharmaceutical lipid-based excipients market

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Pharmaceutical Lipid-Based Excipients Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?

The market size for pharmaceutical lipid-based excipients has shown strong growth in recent years. This market is projected to expand from $1.77 billion in 2025 to $1.86 billion in 2026, at a compound annual growth rate (CAGR) of 5.2%. Historically, this growth can be attributed to factors such as the increasing number of poorly water-soluble drug pipelines, advancements in lipid formulation science, the expansion of pharmaceutical manufacturing, the rising adoption of oral delivery systems, and regulatory support for lipid excipients.

The pharmaceutical lipid-based excipients market is anticipated to show robust growth over the next few years, projected to reach $2.29 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 5.3%. This expansion during the forecast period is attributable to several factors, including an increase in complex drug formulations, a rising demand for improved drug absorption, the expanding use of biologics and oncology drugs, ongoing advancements in lipid technologies, and a growing emphasis on patient-centric formulations. Furthermore, significant trends expected within this period involve the increasing application of lipid excipients for poorly soluble drugs, their broader adoption in both oral and parenteral formulations, a heightened demand for bioavailability-enhancing excipients, the wider deployment of lipid-based drug delivery systems, and an increasing focus on natural and sustainable lipids.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=98910496&type=smp&name=Pharmaceutical%20Lipid-Based%20Excipients%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Pharmaceutical Lipid-Based Excipients Market Demand Drivers Opening New Revenue Streams

The increasing adoption of gene therapy is anticipated to boost the expansion of the pharmaceutical lipid-based excipients market in the future. Gene therapy refers to a medical method focused on altering or manipulating an individual’s genes to address or avert illnesses. This increase in gene therapy is attributed to improvements in delivery systems, which allow for the secure, effective, and precise delivery of genetic material into cells. Pharmaceutical lipid-based excipients augment gene therapy by facilitating effective delivery systems and guaranteeing the stability and targeted movement of genetic material. These excipients contribute to better therapeutic results by safeguarding nucleic acids and aiding cellular absorption, thereby enhancing the efficacy of contemporary treatments. As an illustration, in December 2024, data from the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, indicated that the Food and Drug Administration (FDA) sanctioned 6 gene therapy products in 2023, an increase from five approvals recorded in 2022. Consequently, the growing prevalence of gene therapy is fueling the expansion of the pharmaceutical lipid-based excipients market.

Pharmaceutical Lipid-Based Excipients Market Segments: Where Is Growth Concentrated?

The pharmaceutical lipid-based excipients market covered in this report is segmented –

1) By Excipient Type: Oils, Hydrogenated Vegetable Oils, GMCC, Hard Fats, Medium Chain Triglycerides, Lecithin And Phospholipids, Sodium Oleate, Capri Caprylic Mono Diglyceride, Other Excipient Types

2) By Product Applications: Oral Formulations, Parenteral, Topical Applications, Ophthalmic Applications, Suppositories, Other Product Applications

3) By Disease Application: Cardiovascular Diseases, Neurological Disorders, Oncology, Metabolic Disorders, Hormonal Therapies, Infectious Diseases, Other Disease Applications

4) By Age Group: Pediatric Products (0-18 years), Adult Products (19-64 years), Geriatric Products (65+ years)

5) By End-Use: Pharmaceutical Manufacturers, Contract Development And Manufacturing Organizations, Other End Users

Subsegments:

1) By Oils: Soybean Oil, Olive Oil, Palm Oil, Sunflower Oil, Other Oils

2) By Hydrogenated Vegetable Oils: Hydrogenated Soybean Oil, Hydrogenated Palm Oil, Hydrogenated Cottonseed Oil, Other Hydrogenated Vegetable Oils

3) By GMCC (Glyceryl Mono/Diesters of C16/C18): Glyceryl Monostearate, Glyceryl Distearate, Glyceryl Monopalmitate, Other GMCC

4) By Hard Fats: Hydrogenated Castor Oil, Hydrogenated Palm Kernel Oil, Hydrogenated Coconut Oil, Other Hard Fats

5) By Medium Chain Triglycerides (MCTs): Capric Triglycerides, Caprylic Triglycerides, Caprylic-Capric Triglycerides, Other MCTs

6) By Lecithin and Phospholipids: Soy Lecithin, Egg Lecithin, Phosphatidylcholine, Phosphatidylserine, Other Lecithin and Phospholipids

7) By Sodium Oleate: Pharmaceutical Grade Sodium Oleate, Food Grade Sodium Oleate, Industrial Grade Sodium Oleate

8) By Capri-Caprylic Mono/Diglycerides: Capric-Caprylic Monoglycerides, Capric-Caprylic Diglycerides

9) By Other Excipient Types: Sucrose Esters, Fatty Acid Esters, PEGylated Lipids, Other Miscellaneous Lipids

Pharmaceutical Lipid-Based Excipients Market Trends Powering Strategic Industry Growth

Major companies in the pharmaceutical lipid-based excipients market are concentrating on strategic investments, such as developing advanced Centers of Excellence. These efforts aim to drive innovation, enhance formulation capabilities, support drug delivery research, and reinforce their competitive position across emerging therapeutic areas. For instance, in November 2024, Gattefossé SAS, a France-based chemical manufacturing company, opened a cutting-edge Technical Center of Excellence in Mumbai. This facility is designed to support India’s growing pharma market by offering specialized labs and tailored assistance for excipient innovation, with a particular focus on bioavailability, sustained release, and topical formulations, while simultaneously strengthening its presence in the Asia-Pacific region. The state-of-the-art facility includes pharmaceutical and personal care application laboratories, intended to foster innovation, encourage collaboration, and provide a productive work environment.

Pharmaceutical Lipid-Based Excipients Market Key Participants And Competitive Landscape

Major companies operating in the pharmaceutical lipid-based excipients market are Cargill Incorporated, BASF SE, Merck KGaA, FUJIFILM Corporation, Evonik Industries AG, DuPont de Nemours Inc., Stepan Company, Croda International, Ashland Corporation, NOF CORPORATION, CordenPharma, SEPPIC, Nippon Fine Chemical Co. Ltd., Cayman Chemical, ABITEC Corporation, Creative Biolabs, IOI Oleo GmbH, Lipoid, RuixiBiotechCo.Ltd, Biosynth

View The Full Pharmaceutical Lipid-Based Excipients Market Report:

https://thebusinessresearchcompany.com/report/pharmaceutical-lipid-based-excipients-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Pharmaceutical Lipid-Based Excipients Market Leading Geography: Which Region Contributes The Most Revenue?

Europe was the largest region in the pharmaceutical lipid-based excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical lipid-based excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Pharmaceutical Lipid-Based Excipients Market Forecast Highlighting Growth From $1.86 Billion To $2.28 Billion

The pharmaceutical segment focused on lipid-based excipients has experienced notable expansion in recent years. Projections indicate a rise from a market valuation of $1.77 billion in 2025 to $1.86 billion in 2026, reflecting a compound annual growth rate of 5.2%. This upward trend during the historical period can be linked to several factors, including an increase in drug development pipelines for poorly water-soluble compounds, progress made in the science of lipid formulations, a broadening scope of pharmaceutical production operations, a growing preference for employing oral delivery mechanisms, and regulatory endorsement provided for lipid-based excipient materials.

The market for pharmaceutical lipid-based excipients is projected to experience robust expansion over the coming years. By 2030, its value is anticipated to reach $2.29 billion, reflecting a compound annual growth rate (CAGR) of 5.3%. This forecasted growth is driven by several factors, including the rise of complex drug formulations, a growing need for improved drug absorption, an expansion in biologics and oncology treatments, progress in lipid technology, and a heightened emphasis on patient-centered product design. Key trends shaping this period involve the greater use of lipid excipients to address poorly soluble drugs, their increased application in both oral and parenteral formulations, a rising demand for excipients that enhance bioavailability, the broadening of lipid-based drug delivery platforms, and a stronger focus on natural and sustainable lipid sources.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24374&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

#Pharmaceutical Lipid-Based Excipients Market Growth Factors: Which Forces Are Supporting Market Expansion?

The anticipated expansion of the pharmaceutical lipid-based excipients market is fueled by the increasing adoption of gene therapy. This medical approach focuses on altering or adjusting an individual’s genes to either cure or prevent illnesses. Gene therapy is advancing due to improved delivery methods that ensure the safe, effective, and precise transfer of genetic material into cells. Pharmaceutical lipid-based excipients support gene therapy by facilitating delivery systems that maintain stability and enable targeted genetic transport. These agents boost treatment outcomes by shielding nucleic acids and improving cellular absorption, thereby increasing the efficacy of contemporary therapies. For example, in December 2024, the American Society of Gene & Cell Therapy (ASGCT)—a nonprofit medical and scientific organization based in the US—reported that the Food and Drug Administration (FDA) authorized 6 gene therapy products in 2023, compared to 5 approvals recorded in 2022. Consequently, the growth of the gene therapy field is driving momentum in the pharmaceutical lipid-based excipients market.

Pharmaceutical Lipid-Based Excipients Market Segment Landscape: Which Areas Lead Market Development?

The pharmaceutical lipid-based excipients market covered in this report is segmented –

1) By Excipient Type: Oils, Hydrogenated Vegetable Oils, GMCC, Hard Fats, Medium Chain Triglycerides, Lecithin And Phospholipids, Sodium Oleate, Capri Caprylic Mono Diglyceride, Other Excipient Types

2) By Product Applications: Oral Formulations, Parenteral, Topical Applications, Ophthalmic Applications, Suppositories, Other Product Applications

3) By Disease Application: Cardiovascular Diseases, Neurological Disorders, Oncology, Metabolic Disorders, Hormonal Therapies, Infectious Diseases, Other Disease Applications

4) By Age Group: Pediatric Products (0-18 years), Adult Products (19-64 years), Geriatric Products (65+ years)

5) By End-Use: Pharmaceutical Manufacturers, Contract Development And Manufacturing Organizations, Other End Users

Subsegments:

1) By Oils: Soybean Oil, Olive Oil, Palm Oil, Sunflower Oil, Other Oils

2) By Hydrogenated Vegetable Oils: Hydrogenated Soybean Oil, Hydrogenated Palm Oil, Hydrogenated Cottonseed Oil, Other Hydrogenated Vegetable Oils

3) By GMCC (Glyceryl Mono/Diesters of C16/C18): Glyceryl Monostearate, Glyceryl Distearate, Glyceryl Monopalmitate, Other GMCC

4) By Hard Fats: Hydrogenated Castor Oil, Hydrogenated Palm Kernel Oil, Hydrogenated Coconut Oil, Other Hard Fats

5) By Medium Chain Triglycerides (MCTs): Capric Triglycerides, Caprylic Triglycerides, Caprylic-Capric Triglycerides, Other MCTs

6) By Lecithin and Phospholipids: Soy Lecithin, Egg Lecithin, Phosphatidylcholine, Phosphatidylserine, Other Lecithin and Phospholipids

7) By Sodium Oleate: Pharmaceutical Grade Sodium Oleate, Food Grade Sodium Oleate, Industrial Grade Sodium Oleate

8) By Capri-Caprylic Mono/Diglycerides: Capric-Caprylic Monoglycerides, Capric-Caprylic Diglycerides

9) By Other Excipient Types: Sucrose Esters, Fatty Acid Esters, PEGylated Lipids, Other Miscellaneous Lipids

Pharmaceutical Lipid-Based Excipients Market Industry Trends: What Changes Are Reshaping Demand?

Major players in the pharmaceutical lipid-based excipients sector are channeling resources into strategic investments, particularly the development of advanced Centers of Excellence aimed at stimulating innovation, improving formulation capabilities, facilitating drug delivery research, and bolstering their competitive edge within emerging therapeutic fields. A notable example occurred in November 2024, when Gattefossé SAS, a chemical manufacturing firm based in France, unveiled a new state-of-the-art Technical Center of Excellence in Mumbai. This facility is designed to cater to the expanding pharmaceutical market in India by delivering specialized laboratories and customized support focused on excipient innovation, with an emphasis on bioavailability, sustained release, and topical formulations, thereby reinforcing the company’s footprint across the Asia-Pacific region. The center houses both pharmaceutical and personal care application labs, intended to drive forward innovation, promote collaborative efforts, and create a conducive environment for productive research and development.

Pharmaceutical Lipid-Based Excipients Market Industry Leaders And Market Competition

Major companies operating in the pharmaceutical lipid-based excipients market are Cargill Incorporated, BASF SE, Merck KGaA, FUJIFILM Corporation, Evonik Industries AG, DuPont de Nemours Inc., Stepan Company, Croda International, Ashland Corporation, NOF CORPORATION, CordenPharma, SEPPIC, Nippon Fine Chemical Co. Ltd., Cayman Chemical, ABITEC Corporation, Creative Biolabs, IOI Oleo GmbH, Lipoid, RuixiBiotechCo.Ltd, Biosynth

Access The Complete Pharmaceutical Lipid-Based Excipients Market Report:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-lipid-based-excipients-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Pharmaceutical Lipid-Based Excipients Market Largest Region: Which Geography Holds The Highest Market Share?

Europe was the largest region in the pharmaceutical lipid-based excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical lipid-based excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Are The Forecasted Market Size Figures For The Pharmaceutical Lipid-Based Excipients Market In 2026 And 2030?

The market size for pharmaceutical lipid-based excipients has experienced significant growth in recent years. It is projected to expand from $1.77 billion in 2025 to $1.86 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.2%. Historically, this growth can be attributed to several factors, including an increase in poorly water-soluble drug pipelines, advancements in lipid formulation science, the expansion of pharmaceutical manufacturing, the rising use of oral delivery systems, and regulatory support for lipid excipients.

The pharmaceutical lipid-based excipients market is anticipated to show substantial growth over the next few years, projected to swell to $2.29 billion in 2030, registering a compound annual growth rate (CAGR) of 5.3%. This expansion during the forecast period is attributed to several factors including the increase in complex drug formulations, a rising need for enhanced drug absorption, the broadening scope of biologics and oncology drugs, ongoing advancements in lipid technologies, and a heightened emphasis on patient-centric formulations. Major trends expected in this period encompass the expanded use of lipid excipients for poorly soluble drugs, their growing adoption in both oral and parenteral formulations, an increasing demand for excipients that enhance bioavailability, the expansion of lipid-based drug delivery systems, and a strengthened focus on natural and sustainable lipids.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24374&type=smp

Which Growth Drivers Are Expected To Support The Pharmaceutical Lipid-Based Excipients Market Forward?

The projected increase in gene therapy is poised to stimulate the growth of the pharmaceutical lipid-based excipients market. Gene therapy is a medical approach that involves modifying or manipulating a person’s genes to address or prevent diseases. The escalation in gene therapy is attributed to advancements in delivery systems, as these systems enable the safe, efficient, and targeted transport of genetic material into cells. Pharmaceutical lipid-based excipients enhance gene therapy by facilitating effective delivery systems, ensuring the stability and targeted transport of genetic material. They contribute to better therapeutic outcomes by protecting nucleic acids and promoting cellular uptake, thereby improving the effectiveness of modern treatments. For instance, in December 2024, according to the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, the Food and Drug Administration (FDA) approved 6 gene therapy products in 2023, which was an increase from five approvals in 2022. Thus, the expansion of gene therapy is driving the growth of the pharmaceutical lipid-based excipients market.

What Key Segment Areas Are Included In The Pharmaceutical Lipid-Based Excipients Market Assessment?

The pharmaceutical lipid-based excipients market covered in this report is segmented –

1) By Excipient Type: Oils, Hydrogenated Vegetable Oils, GMCC, Hard Fats, Medium Chain Triglycerides, Lecithin And Phospholipids, Sodium Oleate, Capri Caprylic Mono Diglyceride, Other Excipient Types

2) By Product Applications: Oral Formulations, Parenteral, Topical Applications, Ophthalmic Applications, Suppositories, Other Product Applications

3) By Disease Application: Cardiovascular Diseases, Neurological Disorders, Oncology, Metabolic Disorders, Hormonal Therapies, Infectious Diseases, Other Disease Applications

4) By Age Group: Pediatric Products (0-18 years), Adult Products (19-64 years), Geriatric Products (65+ years)

5) By End-Use: Pharmaceutical Manufacturers, Contract Development And Manufacturing Organizations, Other End Users

Subsegments:

1) By Oils: Soybean Oil, Olive Oil, Palm Oil, Sunflower Oil, Other Oils

2) By Hydrogenated Vegetable Oils: Hydrogenated Soybean Oil, Hydrogenated Palm Oil, Hydrogenated Cottonseed Oil, Other Hydrogenated Vegetable Oils

3) By GMCC (Glyceryl Mono/Diesters of C16/C18): Glyceryl Monostearate, Glyceryl Distearate, Glyceryl Monopalmitate, Other GMCC

4) By Hard Fats: Hydrogenated Castor Oil, Hydrogenated Palm Kernel Oil, Hydrogenated Coconut Oil, Other Hard Fats

5) By Medium Chain Triglycerides (MCTs): Capric Triglycerides, Caprylic Triglycerides, Caprylic-Capric Triglycerides, Other MCTs

6) By Lecithin and Phospholipids: Soy Lecithin, Egg Lecithin, Phosphatidylcholine, Phosphatidylserine, Other Lecithin and Phospholipids

7) By Sodium Oleate: Pharmaceutical Grade Sodium Oleate, Food Grade Sodium Oleate, Industrial Grade Sodium Oleate

8) By Capri-Caprylic Mono/Diglycerides: Capric-Caprylic Monoglycerides, Capric-Caprylic Diglycerides

9) By Other Excipient Types: Sucrose Esters, Fatty Acid Esters, PEGylated Lipids, Other Miscellaneous Lipids

Which Trends Are Expected To Shape The Pharmaceutical Lipid-Based Excipients Market?

Companies operating within the pharmaceutical lipid-based excipients market are prioritizing investments, including strategic funding, to establish advanced Centers of Excellence. These centers are designed to foster innovation, improve formulation skills, support research in drug delivery, and strengthen their market standing in emerging therapeutic areas. An illustration of this trend is Gattefossé SAS, a French chemical manufacturing company, which in November 2024, launched a state-of-the-art Technical Center of Excellence in Mumbai. This facility aims to assist India’s burgeoning pharmaceutical sector by providing specialized laboratories and customized support for excipient innovation, with a particular focus on enhancing bioavailability, sustained release, and topical formulations, while simultaneously solidifying the company’s presence across the Asia-Pacific region. This modern facility integrates pharmaceutical and personal care application laboratories to cultivate innovation, encourage cooperative efforts, and provide an effective working environment.

Which Organizations Are Involved In The Pharmaceutical Lipid-Based Excipients Market?

Major companies operating in the pharmaceutical lipid-based excipients market are Cargill Incorporated, BASF SE, Merck KGaA, FUJIFILM Corporation, Evonik Industries AG, DuPont de Nemours Inc., Stepan Company, Croda International, Ashland Corporation, NOF CORPORATION, CordenPharma, SEPPIC, Nippon Fine Chemical Co. Ltd., Cayman Chemical, ABITEC Corporation, Creative Biolabs, IOI Oleo GmbH, Lipoid, RuixiBiotechCo.Ltd, Biosynth

Access The Complete Pharmaceutical Lipid-Based Excipients Market Report:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-lipid-based-excipients-global-market-report

Which Regional Market Leads The Pharmaceutical Lipid-Based Excipients Market?

Europe was the largest region in the pharmaceutical lipid-based excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical lipid-based excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Pharmaceutical Lipid-Based Excipients Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=24374&type=smp

Browse Through More Reports Similar to the Global Pharmaceutical Lipid-Based Excipients Market 2026, By The Business Research Company

Pharmaceutical Excipient Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report

Organic Pharmaceutical Excipients Market Report 2026

https://www.thebusinessresearchcompany.com/report/organic-pharmaceutical-excipients-global-market-report

Liposomal Drug Delivery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/liposomal-drug-delivery-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Changes In Market Value Are Expected For The Pharmaceutical Lipid-Based Excipients Market Over The 2026–2030 Period?

The pharmaceutical lipid-based excipients market has exhibited robust growth over recent years. It is anticipated to increase from $1.77 billion in 2025 to $1.86 billion in 2026, at a compound annual growth rate (CAGR) of 5.2%. The expansion observed historically can be credited to the rising number of poorly water-soluble drug pipelines, advancements in lipid formulation science, the expansion of pharmaceutical manufacturing, the growing utilization of oral delivery systems, and regulatory support for lipid excipients.

The pharmaceutical lipid-based excipients market size is expected to undergo robust expansion in the coming years. It is projected to achieve a valuation of $2.29 billion by 2030, growing at a compound annual growth rate (CAGR) of 5.3%. This anticipated growth during the forecast period is attributable to the increase in complex drug formulations, a surging demand for enhanced drug absorption, the expansion of biologics and oncology drugs, advancements in lipid technologies, and an escalating focus on patient-centric formulations. Significant trends for the forecast period include the increasing utilization of lipid excipients for drugs with poor solubility, their rising adoption in oral and parenteral formulations, a growing requirement for bioavailability-enhancing excipients, the broader development of lipid-based drug delivery systems, and a heightened emphasis on natural and sustainable lipids.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24374&type=smp

What Primary Drivers Are Shaping The Pharmaceutical Lipid-Based Excipients Market?

The anticipated expansion of the pharmaceutical lipid-based excipients market is linked to the increasing prevalence of gene therapy. This medical approach focuses on altering or manipulating an individual’s genes to either cure or avert illnesses. Its growing prominence stems from progress in delivery mechanisms, which facilitate the secure, effective, and precise conveyance of genetic material into cellular structures. Pharmaceutical lipid-based excipients improve gene therapy’s efficacy by providing efficient delivery systems that ensure the stability and specific transport of genetic material. These excipients contribute to better therapeutic results through their role in safeguarding nucleic acids and aiding cellular absorption, thereby boosting the impact of contemporary treatments. As an illustration, in December 2024, the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, reported that the Food and Drug Administration (FDA) granted approval to 6 gene therapy products in 2023, an increase from five approvals in 2022. Consequently, the expansion of gene therapy is a key factor propelling the pharmaceutical lipid-based excipients market forward.

How Is Segmentation Applied In The Pharmaceutical Lipid-Based Excipients Market Segment Analysis?

The pharmaceutical lipid-based excipients market covered in this report is segmented –

1) By Excipient Type: Oils, Hydrogenated Vegetable Oils, GMCC, Hard Fats, Medium Chain Triglycerides, Lecithin And Phospholipids, Sodium Oleate, Capri Caprylic Mono Diglyceride, Other Excipient Types

2) By Product Applications: Oral Formulations, Parenteral, Topical Applications, Ophthalmic Applications, Suppositories, Other Product Applications

3) By Disease Application: Cardiovascular Diseases, Neurological Disorders, Oncology, Metabolic Disorders, Hormonal Therapies, Infectious Diseases, Other Disease Applications

4) By Age Group: Pediatric Products (0-18 years), Adult Products (19-64 years), Geriatric Products (65+ years)

5) By End-Use: Pharmaceutical Manufacturers, Contract Development And Manufacturing Organizations, Other End Users

Subsegments:

1) By Oils: Soybean Oil, Olive Oil, Palm Oil, Sunflower Oil, Other Oils

2) By Hydrogenated Vegetable Oils: Hydrogenated Soybean Oil, Hydrogenated Palm Oil, Hydrogenated Cottonseed Oil, Other Hydrogenated Vegetable Oils

3) By GMCC (Glyceryl Mono/Diesters of C16/C18): Glyceryl Monostearate, Glyceryl Distearate, Glyceryl Monopalmitate, Other GMCC

4) By Hard Fats: Hydrogenated Castor Oil, Hydrogenated Palm Kernel Oil, Hydrogenated Coconut Oil, Other Hard Fats

5) By Medium Chain Triglycerides (MCTs): Capric Triglycerides, Caprylic Triglycerides, Caprylic-Capric Triglycerides, Other MCTs

6) By Lecithin and Phospholipids: Soy Lecithin, Egg Lecithin, Phosphatidylcholine, Phosphatidylserine, Other Lecithin and Phospholipids

7) By Sodium Oleate: Pharmaceutical Grade Sodium Oleate, Food Grade Sodium Oleate, Industrial Grade Sodium Oleate

8) By Capri-Caprylic Mono/Diglycerides: Capric-Caprylic Monoglycerides, Capric-Caprylic Diglycerides

9) By Other Excipient Types: Sucrose Esters, Fatty Acid Esters, PEGylated Lipids, Other Miscellaneous Lipids

What Emerging Trends Are Seen In The Pharmaceutical Lipid-Based Excipients Market?

Leading companies in the pharmaceutical lipid-based excipients market are prioritizing investments, such as strategic capital to establish advanced Centers of Excellence. These initiatives aim to drive innovation, enhance formulation capabilities, support drug delivery research, and strengthen their competitive stance in emerging therapeutic areas. For instance, in November 2024, Gattefossé SAS, a France-based chemical manufacturing company, inaugurated a cutting-edge Technical Center of Excellence in Mumbai. This facility is designed to support India’s burgeoning pharma market by offering specialized laboratories and tailored support for excipient innovation, focusing on bioavailability, sustained release, and topical formulations, while simultaneously expanding its presence in the Asia-Pacific region. The sophisticated center features pharmaceutical and personal care application laboratories, fostering innovation, promoting collaboration, and providing a productive work environment.

Who Are The Companies Participating In The Pharmaceutical Lipid-Based Excipients Market Environment?

Major companies operating in the pharmaceutical lipid-based excipients market are Cargill Incorporated, BASF SE, Merck KGaA, FUJIFILM Corporation, Evonik Industries AG, DuPont de Nemours Inc., Stepan Company, Croda International, Ashland Corporation, NOF CORPORATION, CordenPharma, SEPPIC, Nippon Fine Chemical Co. Ltd., Cayman Chemical, ABITEC Corporation, Creative Biolabs, IOI Oleo GmbH, Lipoid, RuixiBiotechCo.Ltd, Biosynth

Get The Full Pharmaceutical Lipid-Based Excipients Market Report:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-lipid-based-excipients-global-market-report

Which Region Holds The Highest Market Share In The Pharmaceutical Lipid-Based Excipients Market?

Europe was the largest region in the pharmaceutical lipid-based excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical lipid-based excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Pharmaceutical Lipid-Based Excipients Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-lipid-based-excipients-global-market-report

Browse Through More Reports Similar to the Global Pharmaceutical Lipid-Based Excipients Market 2026, By The Business Research Company

Pharmaceutical Excipient Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report

Organic Pharmaceutical Excipients Market Report 2026

https://www.thebusinessresearchcompany.com/report/organic-pharmaceutical-excipients-global-market-report

Liposomal Drug Delivery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/liposomal-drug-delivery-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Pharmaceutical Lipid-Based Excipients Market By The End Of 2030?

The pharmaceutical lipid-based excipients market size has experienced significant expansion in recent years. It is anticipated to grow from $1.77 billion in 2025 to $1.86 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.2%. The historical increase can be attributed to the rise in poorly water-soluble drug pipelines, advancements in lipid formulation science, the expansion of pharmaceutical manufacturing, increasing use of oral delivery systems, and regulatory support for lipid excipients.

The pharmaceutical lipid-based excipients market is projected to experience substantial expansion over the upcoming years. By 2030, this market is anticipated to reach a valuation of $2.29 billion, demonstrating a compound annual growth rate (CAGR) of 5.3%. This expansion during the projection period stems from several factors, including the proliferation of intricate drug formulations, a heightened need for improved drug absorption, the broader application of biologics and oncology medications, innovations in lipid technologies, and an escalating emphasis on patient-focused formulations. Key trends anticipated during the forecast period involve the expanded utilization of lipid excipients for drugs with low solubility, their increasing incorporation into oral and parenteral formulations, a greater call for excipients that boost bioavailability, the development of more lipid-based drug delivery systems, and a heightened interest in natural and environmentally friendly lipids.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24374&type=smp

What Primary Drivers Are Shaping The Development Of The Pharmaceutical Lipid-Based Excipients Market?

The increasing prevalence of gene therapy is anticipated to drive the expansion of the pharmaceutical lipid-based excipients market. Gene therapy is a medical method focused on modifying or manipulating an individual’s genes to treat or prevent diseases. The rise in gene therapy is attributed to advancements in delivery systems, which facilitate the safe, efficient, and targeted transport of genetic material into cells. Pharmaceutical lipid-based excipients support gene therapy by enabling effective delivery systems, ensuring the stability and precise transport of genetic material. They contribute to improved therapeutic outcomes by protecting nucleic acids and facilitating cellular uptake, thereby advancing the efficacy of modern treatments. For instance, in December 2024, data from the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, indicated that the Food and Drug Administration (FDA) approved 6 gene therapy products in 2023, an increase from five approvals in 2022. Therefore, the growth in gene therapy is propelling the pharmaceutical lipid-based excipients market forward.

Which Segment Classifications Shape The Pharmaceutical Lipid-Based Excipients Market?

The pharmaceutical lipid-based excipients market covered in this report is segmented –

1) By Excipient Type: Oils, Hydrogenated Vegetable Oils, GMCC, Hard Fats, Medium Chain Triglycerides, Lecithin And Phospholipids, Sodium Oleate, Capri Caprylic Mono Diglyceride, Other Excipient Types

2) By Product Applications: Oral Formulations, Parenteral, Topical Applications, Ophthalmic Applications, Suppositories, Other Product Applications

3) By Disease Application: Cardiovascular Diseases, Neurological Disorders, Oncology, Metabolic Disorders, Hormonal Therapies, Infectious Diseases, Other Disease Applications

4) By Age Group: Pediatric Products (0-18 years), Adult Products (19-64 years), Geriatric Products (65+ years)

5) By End-Use: Pharmaceutical Manufacturers, Contract Development And Manufacturing Organizations, Other End Users

Subsegments:

1) By Oils: Soybean Oil, Olive Oil, Palm Oil, Sunflower Oil, Other Oils

2) By Hydrogenated Vegetable Oils: Hydrogenated Soybean Oil, Hydrogenated Palm Oil, Hydrogenated Cottonseed Oil, Other Hydrogenated Vegetable Oils

3) By GMCC (Glyceryl Mono/Diesters of C16/C18): Glyceryl Monostearate, Glyceryl Distearate, Glyceryl Monopalmitate, Other GMCC

4) By Hard Fats: Hydrogenated Castor Oil, Hydrogenated Palm Kernel Oil, Hydrogenated Coconut Oil, Other Hard Fats

5) By Medium Chain Triglycerides (MCTs): Capric Triglycerides, Caprylic Triglycerides, Caprylic-Capric Triglycerides, Other MCTs

6) By Lecithin and Phospholipids: Soy Lecithin, Egg Lecithin, Phosphatidylcholine, Phosphatidylserine, Other Lecithin and Phospholipids

7) By Sodium Oleate: Pharmaceutical Grade Sodium Oleate, Food Grade Sodium Oleate, Industrial Grade Sodium Oleate

8) By Capri-Caprylic Mono/Diglycerides: Capric-Caprylic Monoglycerides, Capric-Caprylic Diglycerides

9) By Other Excipient Types: Sucrose Esters, Fatty Acid Esters, PEGylated Lipids, Other Miscellaneous Lipids

How Are Trends Impacting The Pharmaceutical Lipid-Based Excipients Market?

Major companies operating in the pharmaceutical lipid-based excipients market are prioritizing investments, including strategic initiatives to establish advanced Centers of Excellence. These centers aim to drive innovation, enhance formulation capabilities, support drug delivery research, and strengthen their competitive standing in emerging therapeutic areas. As an illustration, in November 2024, Gattefossé SAS, a France-based chemical manufacturing company, opened a cutting-edge Technical Center of Excellence in Mumbai. This facility is designed to support India’s growing pharma market by providing specialized laboratories and tailored assistance for excipient innovation, with a focus on bioavailability, sustained release, and topical formulations, while simultaneously reinforcing its presence in the Asia-Pacific region. The state-of-the-art facility incorporates pharmaceutical and personal care application laboratories to foster innovation, encourage collaboration, and provide a productive work environment.

Which Companies Are Expanding Their Footprint In The Pharmaceutical Lipid-Based Excipients Market?

Major companies operating in the pharmaceutical lipid-based excipients market are Cargill Incorporated, BASF SE, Merck KGaA, FUJIFILM Corporation, Evonik Industries AG, DuPont de Nemours Inc., Stepan Company, Croda International, Ashland Corporation, NOF CORPORATION, CordenPharma, SEPPIC, Nippon Fine Chemical Co. Ltd., Cayman Chemical, ABITEC Corporation, Creative Biolabs, IOI Oleo GmbH, Lipoid, RuixiBiotechCo.Ltd, Biosynth

Read the full pharmaceutical lipid-based excipients market report here:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-lipid-based-excipients-global-market-report

How Does The Pharmaceutical Lipid-Based Excipients Market Perform Across Major Global Regions?

Europe was the largest region in the pharmaceutical lipid-based excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical lipid-based excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Pharmaceutical Lipid-Based Excipients Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24374&type=smp

Browse Through More Reports Similar to the Global Pharmaceutical Lipid-Based Excipients Market 2026, By The Business Research Company

Pharmaceutical Excipient Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report

Organic Pharmaceutical Excipients Market Report 2026

https://www.thebusinessresearchcompany.com/report/organic-pharmaceutical-excipients-global-market-report

Liposomal Drug Delivery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/liposomal-drug-delivery-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the pharmaceutical lipid-based excipients market from 2026–2035 with trusted insights from The Business Research Company

What is the estimated market size of the Pharmaceutical Lipid-Based Excipients Market by the end of 2030?

The market size for pharmaceutical lipid-based excipients has demonstrated strong expansion in recent years. It is projected to increase from $1.77 billion in 2025 to $1.86 billion in 2026, reflecting a compound annual growth rate (CAGR) of 5.2%. This historical growth can be linked to factors such as the rise in poorly water-soluble drug pipelines, advancements in lipid formulation science, the growth of pharmaceutical manufacturing, an increased utilization of oral delivery systems, and regulatory encouragement for lipid excipients.

The pharmaceutical lipid-based excipients market is anticipated to experience robust expansion in the coming years. Its valuation is projected to reach $2.29 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.3%. This anticipated growth during the forecast timeframe is primarily driven by factors such as the rise in complex drug formulations, a heightened need for improved drug absorption, the broader application of biologics and oncology medications, innovations in lipid technologies, and an increased emphasis on patient-centered formulations. Key trends emerging within this period encompass the expanded application of lipid excipients for drugs with low solubility, their increasing integration into oral and parenteral drug preparations, a surge in the need for excipients that boost bioavailability, the wider development of lipid-based drug delivery methods, and a growing interest in naturally derived and sustainable lipids.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24374&type=smp

What Drivers Are Shaping Future Opportunities In The Pharmaceutical Lipid-Based Excipients Market?

The expanding field of gene therapy is anticipated to boost the pharmaceutical lipid-based excipients market’s growth in the future. Gene therapy refers to a medical approach where an individual’s genes are altered or adjusted to address or avert illnesses. This increase in gene therapy is attributable to improved delivery systems, which facilitate the secure, effective, and targeted transfer of genetic material into cells. Pharmaceutical lipid-based excipients play a crucial role in advancing gene therapy by supporting efficient delivery mechanisms, guaranteeing the stability and precise targeting of genetic material. These excipients contribute to better therapeutic results through the protection of nucleic acids and by aiding cellular absorption, thereby enhancing the efficacy of contemporary treatments. An illustration of this trend is seen in data from December 2024 by the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, which indicated that the Food and Drug Administration (FDA) sanctioned 6 gene therapy products in 2023, an increase from five approvals recorded in 2022. Consequently, the expansion of gene therapy is a key factor propelling the development of the pharmaceutical lipid-based excipients market.

Which Segments Are Gaining Traction In The Pharmaceutical Lipid-Based Excipients Market?

The pharmaceutical lipid-based excipients market covered in this report is segmented –

1) By Excipient Type: Oils, Hydrogenated Vegetable Oils, GMCC, Hard Fats, Medium Chain Triglycerides, Lecithin And Phospholipids, Sodium Oleate, Capri Caprylic Mono Diglyceride, Other Excipient Types

2) By Product Applications: Oral Formulations, Parenteral, Topical Applications, Ophthalmic Applications, Suppositories, Other Product Applications

3) By Disease Application: Cardiovascular Diseases, Neurological Disorders, Oncology, Metabolic Disorders, Hormonal Therapies, Infectious Diseases, Other Disease Applications

4) By Age Group: Pediatric Products (0-18 years), Adult Products (19-64 years), Geriatric Products (65+ years)

5) By End-Use: Pharmaceutical Manufacturers, Contract Development And Manufacturing Organizations, Other End Users

Subsegments:

1) By Oils: Soybean Oil, Olive Oil, Palm Oil, Sunflower Oil, Other Oils

2) By Hydrogenated Vegetable Oils: Hydrogenated Soybean Oil, Hydrogenated Palm Oil, Hydrogenated Cottonseed Oil, Other Hydrogenated Vegetable Oils

3) By GMCC (Glyceryl Mono/Diesters of C16/C18): Glyceryl Monostearate, Glyceryl Distearate, Glyceryl Monopalmitate, Other GMCC

4) By Hard Fats: Hydrogenated Castor Oil, Hydrogenated Palm Kernel Oil, Hydrogenated Coconut Oil, Other Hard Fats

5) By Medium Chain Triglycerides (MCTs): Capric Triglycerides, Caprylic Triglycerides, Caprylic-Capric Triglycerides, Other MCTs

6) By Lecithin and Phospholipids: Soy Lecithin, Egg Lecithin, Phosphatidylcholine, Phosphatidylserine, Other Lecithin and Phospholipids

7) By Sodium Oleate: Pharmaceutical Grade Sodium Oleate, Food Grade Sodium Oleate, Industrial Grade Sodium Oleate

8) By Capri-Caprylic Mono/Diglycerides: Capric-Caprylic Monoglycerides, Capric-Caprylic Diglycerides

9) By Other Excipient Types: Sucrose Esters, Fatty Acid Esters, PEGylated Lipids, Other Miscellaneous Lipids

What Trends Are Projected To Support The Growth Of The Pharmaceutical Lipid-Based Excipients Market?

Leading companies in the pharmaceutical lipid-based excipients market are concentrating on investments, including strategic capital allocation for developing sophisticated Centers of Excellence. These initiatives aim to stimulate innovation, improve formulation proficiencies, advance drug delivery investigations, and bolster their competitive stance in evolving therapeutic sectors. For example, in November 2024, Gattefossé SAS, a chemical manufacturing company from France, inaugurated a cutting-edge Technical Center of Excellence in Mumbai. This facility is designed to support India’s burgeoning pharma market by providing specialized laboratories and customized assistance for excipient advancements, with a particular emphasis on bioavailability, sustained release, and topical formulations, thereby reinforcing its foothold in the Asia-Pacific region. This modern facility features application laboratories for both pharmaceutical and personal care products, intended to cultivate innovation, encourage cooperative efforts, and establish a productive professional environment.

Who Are The Core Companies Influencing Trends In The Pharmaceutical Lipid-Based Excipients Market?

Major companies operating in the pharmaceutical lipid-based excipients market are Cargill Incorporated, BASF SE, Merck KGaA, FUJIFILM Corporation, Evonik Industries AG, DuPont de Nemours Inc., Stepan Company, Croda International, Ashland Corporation, NOF CORPORATION, CordenPharma, SEPPIC, Nippon Fine Chemical Co. Ltd., Cayman Chemical, ABITEC Corporation, Creative Biolabs, IOI Oleo GmbH, Lipoid, RuixiBiotechCo.Ltd, Biosynth

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-lipid-based-excipients-global-market-report

Which Regions Are Projected To Dominate The Pharmaceutical Lipid-Based Excipients Market In The Coming Years?

Europe was the largest region in the pharmaceutical lipid-based excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical lipid-based excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Pharmaceutical Lipid-Based Excipients Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24374&type=smp

Browse Through More Reports Similar to the Global Pharmaceutical Lipid-Based Excipients Market 2026, By The Business Research Company

Pharmaceutical Excipient Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report

Organic Pharmaceutical Excipients Market Report 2026

https://www.thebusinessresearchcompany.com/report/organic-pharmaceutical-excipients-global-market-report

Liposomal Drug Delivery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/liposomal-drug-delivery-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the pharmaceutical lipid-based excipients market from 2025–2034 with trusted insights from The Business Research Company

What Is The Base Market Size For The Pharmaceutical Lipid-Based Excipients Market Today And What Will It Reach By 2029?

The pharmaceutical lipid-based excipients market has demonstrated consistent expansion in recent years. This market is set to expand from $1.69 billion in 2024 to $1.77 billion in 2025, achieving a compound annual growth rate (CAGR) of 4.7%. The growth observed in previous periods can be linked to factors such as the increasing occurrence of poorly water-soluble drugs, a greater requirement for controlled and targeted drug delivery, rising investments within the pharmaceutical industry, broader utilization of oral solid dosage forms, an intensified focus on enhancing drug bioavailability, and the regulatory approval of lipid excipients in innovative formulations.

The pharmaceutical lipid-based excipients market size is projected to undergo significant expansion in the coming years. This market is expected to grow to $2.17 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 5.2%. The anticipated growth during this period can be attributed to the increasing need for sophisticated drug delivery systems, the rising adoption of mRNA and gene therapies, a growing pipeline of poorly water-soluble drugs, an intensifying focus on personalized medicine, supportive regulatory frameworks, and strategic financial commitments in biopharmaceutical manufacturing infrastructure. Prominent trends throughout the forecast period include innovations in lipid nanoparticle delivery systems, the widespread integration of mRNA and gene therapies, enhanced solubility solutions for poorly water-soluble drugs, an expansion of biocompatible and sustainable lipid sources, improved manufacturing scalability, and increased application in oral and injectable formulations.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24374&type=smp

What Factors Are Boosting The Pharmaceutical Lipid-Based Excipients Market?

The expanding application of gene therapy is anticipated to boost the pharmaceutical lipid-based excipients market. This medical approach involves altering or manipulating a person’s genes to treat or prevent disease. The increasing adoption of gene therapy is attributed to advancements in delivery systems, which enable safe, efficient, and targeted transport of genetic material into cells. Pharmaceutical lipid-based excipients enhance gene therapy by facilitating efficient delivery systems, ensuring stability and precise transport of genetic material. These excipients improve therapeutic outcomes by protecting nucleic acids and promoting cellular uptake, thereby advancing the effectiveness of modern treatments. For instance, in December 2024, the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, reported that the Food and Drug Administration (FDA) approved six gene therapy products in 2023, an increase from five approvals in 2022. Consequently, the growth in gene therapy is a primary driver for the pharmaceutical lipid-based excipients market.

How Is The Pharmaceutical Lipid-Based Excipients Market Categorized By Application, Type, And Region?

The pharmaceutical lipid-based excipients market covered in this report is segmented –

1) By Excipient Type: Oils, Hydrogenated Vegetable Oils, GMCC, Hard Fats, Medium Chain Triglycerides, Lecithin And Phospholipids, Sodium Oleate, Capri Caprylic Mono Diglyceride, Other Excipient Types

2) By Product Applications: Oral Formulations, Parenteral, Topical Applications, Ophthalmic Applications, Suppositories, Other Product Applications

3) By Disease Application: Cardiovascular Diseases, Neurological Disorders, Oncology, Metabolic Disorders, Hormonal Therapies, Infectious Diseases, Other Disease Applications

4) By Age Group: Pediatric Products (0-18 years), Adult Products (19-64 years), Geriatric Products (65+ years)

5) By End-Use: Pharmaceutical Manufacturers, Contract Development And Manufacturing Organizations, Other End Users

Subsegments:

1) By Oils: Soybean Oil, Olive Oil, Palm Oil, Sunflower Oil, Other Oils

2) By Hydrogenated Vegetable Oils: Hydrogenated Soybean Oil, Hydrogenated Palm Oil, Hydrogenated Cottonseed Oil, Other Hydrogenated Vegetable Oils

3) By GMCC (Glyceryl Mono/Diesters of C16/C18): Glyceryl Monostearate, Glyceryl Distearate, Glyceryl Monopalmitate, Other GMCC

4) By Hard Fats: Hydrogenated Castor Oil, Hydrogenated Palm Kernel Oil, Hydrogenated Coconut Oil, Other Hard Fats

5) By Medium Chain Triglycerides (MCTs): Capric Triglycerides, Caprylic Triglycerides, Caprylic-Capric Triglycerides, Other MCTs

6) By Lecithin and Phospholipids: Soy Lecithin, Egg Lecithin, Phosphatidylcholine, Phosphatidylserine, Other Lecithin and Phospholipids

7) By Sodium Oleate: Pharmaceutical Grade Sodium Oleate, Food Grade Sodium Oleate, Industrial Grade Sodium Oleate

8) By Capri-Caprylic Mono/Diglycerides: Capric-Caprylic Monoglycerides, Capric-Caprylic Diglycerides

9) By Other Excipient Types: Sucrose Esters, Fatty Acid Esters, PEGylated Lipids, Other Miscellaneous Lipids

How Are Technological Trends Affecting The Pharmaceutical Lipid-Based Excipients Market Growth?

Leading companies operating within the pharmaceutical lipid-based excipients market are prioritizing strategic investments, such as establishing advanced Centers of Excellence, to drive innovation, enhance formulation capabilities, support drug delivery research, and strengthen their competitive presence in emerging therapeutic areas. For instance, in November 2024, Gattefossé SAS, a chemical manufacturing company based in France, inaugurated a cutting-edge Technical Center of Excellence in Mumbai. This facility aims to support India’s burgeoning pharma market by providing specialized laboratories and tailored assistance for excipient innovation, with particular emphasis on bioavailability, sustained release, and topical formulations, while simultaneously reinforcing its footprint in the Asia-Pacific region. The state-of-the-art center features pharmaceutical and personal care application laboratories, designed to foster innovation, encourage collaboration, and offer a productive work environment.

Who Are The Global Leaders Steering The Pharmaceutical Lipid-Based Excipients Market Forward?

Major companies operating in the pharmaceutical lipid-based excipients market are Cargill Incorporated, BASF SE, Merck KGaA, FUJIFILM Corporation, Evonik Industries AG, DuPont de Nemours Inc., Stepan Company, Croda International, Ashland Corporation, NOF CORPORATION, CordenPharma, SEPPIC, Nippon Fine Chemical Co. Ltd., Cayman Chemical, ABITEC Corporation, Creative Biolabs, IOI Oleo GmbH, Lipoid, RuixiBiotechCo.Ltd, Biosynth

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-lipid-based-excipients-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Pharmaceutical Lipid-Based Excipients Market?

Europe was the largest region in the pharmaceutical lipid-based excipients market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical lipid-based excipients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=24374&type=smp

Browse Through More Reports Similar to the Global Pharmaceutical Lipid-Based Excipients Market 2025, By The Business Research Company

Lipid Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/lipid-global-market-report

Phospholipid Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/phospholipid-global-market-report

Lipid Panel Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/lipid-panel-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Pharmaceutical Lipid-Based Excipients Industry Expected To Reach By 2029, Starting From 2025 Levels?

The market for pharmaceutical lipid-based excipients has experienced consistent expansion over recent years. This market is projected to expand from $1.69 billion in 2024 to $1.77 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 4.7%. This historical expansion is primarily due to several factors, including an increased prevalence of poorly water-soluble drugs, a heightened demand for controlled and targeted drug release systems, a rise in pharmaceutical investments, wider adoption of oral solid dosage forms, an intensified focus on enhancing drug bioavailability, and the regulatory approval of lipid excipients in new formulations.

The pharmaceutical lipid-based excipients market size is expected to undergo substantial expansion in the coming years. It is forecast to reach $2.17 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 5.2%. This growth during the forecast period can be attributed to several factors, including the increasing demand for advanced drug delivery systems, the growing adoption of mRNA and gene therapies, an expanding pipeline of poorly water-soluble drugs, a heightened focus on personalized medicine, supportive regulatory frameworks, and strategic investments in biopharmaceutical manufacturing infrastructure. Prominent trends for this period include innovations in lipid nanoparticle delivery systems, the continued integration of mRNA and gene therapies, enhanced solubility solutions for poorly water-soluble drugs, the expansion of biocompatible and sustainable lipid sources, improved manufacturing scalability, and increased application in oral and injectable formulations.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24374&type=smp

Which Drivers Are Impacting The Pharmaceutical Lipid-Based Excipients Market?

The future expansion of the pharmaceutical lipid-based excipients market is anticipated to be fueled by the growing prevalence of gene therapy. Gene therapy is defined as a medical approach focused on altering or controlling an individual’s genes to address or avert illnesses. The increased adoption of gene therapy stems from progress in delivery systems, which facilitate the secure, effective, and precise delivery of genetic material into cells. Pharmaceutical lipid-based excipients improve gene therapy’s efficacy by supporting robust delivery mechanisms, guaranteeing the stability and directed movement of genetic material. These excipients boost therapeutic results by safeguarding nucleic acids and promoting cellular absorption, thereby enhancing the impact of contemporary therapies. As an illustration, the American Society of Gene & Cell Therapy (ASGCT), a non-profit medical and scientific organization based in the US, reported in December 2024 that the Food and Drug Administration (FDA) sanctioned six gene therapy products in 2023, an increase from five approvals recorded in 2022. Consequently, the expanding field of gene therapy is propelling the development of the pharmaceutical lipid-based excipients market.

What Are The Leading Segments Analyzed In The Pharmaceutical Lipid-Based Excipients Market?

The pharmaceutical lipid-based excipients market covered in this report is segmented –

1) By Excipient Type: Oils, Hydrogenated Vegetable Oils, GMCC, Hard Fats, Medium Chain Triglycerides, Lecithin And Phospholipids, Sodium Oleate, Capri Caprylic Mono Diglyceride, Other Excipient Types

2) By Product Applications: Oral Formulations, Parenteral, Topical Applications, Ophthalmic Applications, Suppositories, Other Product Applications

3) By Disease Application: Cardiovascular Diseases, Neurological Disorders, Oncology, Metabolic Disorders, Hormonal Therapies, Infectious Diseases, Other Disease Applications

4) By Age Group: Pediatric Products (0-18 years), Adult Products (19-64 years), Geriatric Products (65+ years)

5) By End-Use: Pharmaceutical Manufacturers, Contract Development And Manufacturing Organizations, Other End Users

Subsegments:

1) By Oils: Soybean Oil, Olive Oil, Palm Oil, Sunflower Oil, Other Oils

2) By Hydrogenated Vegetable Oils: Hydrogenated Soybean Oil, Hydrogenated Palm Oil, Hydrogenated Cottonseed Oil, Other Hydrogenated Vegetable Oils

3) By GMCC (Glyceryl Mono/Diesters of C16/C18): Glyceryl Monostearate, Glyceryl Distearate, Glyceryl Monopalmitate, Other GMCC

4) By Hard Fats: Hydrogenated Castor Oil, Hydrogenated Palm Kernel Oil, Hydrogenated Coconut Oil, Other Hard Fats

5) By Medium Chain Triglycerides (MCTs): Capric Triglycerides, Caprylic Triglycerides, Caprylic-Capric Triglycerides, Other MCTs

6) By Lecithin and Phospholipids: Soy Lecithin, Egg Lecithin, Phosphatidylcholine, Phosphatidylserine, Other Lecithin and Phospholipids

7) By Sodium Oleate: Pharmaceutical Grade Sodium Oleate, Food Grade Sodium Oleate, Industrial Grade Sodium Oleate

8) By Capri-Caprylic Mono/Diglycerides: Capric-Caprylic Monoglycerides, Capric-Caprylic Diglycerides

9) By Other Excipient Types: Sucrose Esters, Fatty Acid Esters, PEGylated Lipids, Other Miscellaneous Lipids

Which Competitive Trends Are Defining The Pharmaceutical Lipid-Based Excipients Market Structure?

Leading companies in the pharmaceutical lipid-based excipients market are channeling investments into strategic initiatives, such as establishing advanced Centers of Excellence, to stimulate innovation, enhance formulation capabilities, advance drug delivery research, and reinforce their competitive position across emerging therapeutic areas. For example, in November 2024, Gattefossé SAS, a chemical manufacturing company based in France, inaugurated a cutting-edge Technical Center of Excellence in Mumbai. This center aims to serve India’s expanding pharma market by providing specialized laboratories and customized assistance for excipient innovation, with a specific emphasis on bioavailability, sustained release, and topical formulations, simultaneously bolstering its market presence in the Asia-Pacific region. This modern facility includes dedicated pharmaceutical and personal care application laboratories to cultivate new ideas, encourage teamwork, and create an efficient working environment.

Which Global Market Leaders Are Shaping The Future Of The Pharmaceutical Lipid-Based Excipients Sector?

Major companies operating in the pharmaceutical lipid-based excipients market are Cargill Incorporated, BASF SE, Merck KGaA, FUJIFILM Corporation, Evonik Industries AG, DuPont de Nemours Inc., Stepan Company, Croda International, Ashland Corporation, NOF CORPORATION, CordenPharma, SEPPIC, Nippon Fine Chemical Co. Ltd., Cayman Chemical, ABITEC Corporation, Creative Biolabs, IOI Oleo GmbH, Lipoid, RuixiBiotechCo.Ltd, Biosynth

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-lipid-based-excipients-global-market-report

How Do Regional Market Performances Compare Within The Pharmaceutical Lipid-Based Excipients Industry?

Europe was the largest region in the pharmaceutical lipid-based excipients market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical lipid-based excipients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Pharmaceutical Lipid-Based Excipients Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24374&type=smp

Browse Through More Reports Similar to the Global Pharmaceutical Lipid-Based Excipients Market 2025, By The Business Research Company

Lipid Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/lipid-global-market-report

Phospholipid Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/phospholipid-global-market-report

Lipid Panel Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/lipid-panel-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Pharmaceutical Lipid-Based Excipients Market Through 2034?

The size of the pharmaceutical lipid-based excipients market has seen consistent expansion over recent years. The market value is projected to rise from $1.69 billion in 2024 to $1.77 billion in 2025, exemplifying a compound annual growth rate (CAGR) of 4.7%. This historic period of growth can be accredited to factors such as the increased prevalence of poorly water-soluble drugs, the growing demand for controlled and targeted drug release, amplified pharmaceutical investments, the widening utilization of oral solid dosage forms, an intensified focus on enhancing drug bioavailability, and regulatory approval of lipid excipients in innovative formulations.

Expectations are high for substantial expansion in the pharmaceutical lipid-based excipients market in the coming years. Its anticipated rise is predicted to reach $2.17 billion in 2029 with a compound annual growth rate (CAGR) of 5.2%. This projected growth during the forecast period is a consequence of an increase in demand for sophisticated drug delivery systems and a greater uptake of mRNA and gene therapies. Other influencing factors include the development of a larger pipeline for drugs with poor water solubility, a rising emphasis on personalized medicine, supportive regulatory frameworks and strategic investments in the biopharmaceutical manufacturing landscape. Trends forecasted for this period involve innovations in lipid nanoparticle delivery systems, greater use of mRNA and gene therapies, evolving solubility solutions for poorly water-soluble drugs, widening of biocompatible and sustainable lipid resources, enhanced manufacturing scalability, and broader adoption in oral and injectable formulations.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24374&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Pharmaceutical Lipid-Based Excipients Market?

The increase in gene therapy practices is predicted to drive the expansion of the pharmaceutical lipid-based excipients market. Gene therapy, a medical method that modifies or manipulates an individual’s genes to prevent or treat diseases, has been increasingly adopted due to the advancements in delivery systems. These systems provide safe, efficient, and targeted transportation of genetic material into cells. Pharmaceutical lipid-based excipients contribute to the success of gene therapy by ensuring efficient delivery systems, stability, and targeted transportation of genetic material. By safeguarding the nucleic acids and promoting cellular absorption, they enhance the therapeutic results, increasing the efficiency of contemporary treatments. For instance, the American Society of Gene & Cell Therapy (ASGCT), a non-profit medical and scientific entity based in the US, highlighted in December 2024 that the Food and Drug Administration (FDA) had given approval to six gene therapy products in 2023, an increase from the five approved in the previous year. Consequently, the growth in gene therapy is fuelling the expansion of the pharmaceutical lipid-based excipients market.

Which Key Market Segments Comprise the Pharmaceutical Lipid-Based Excipients Market and Drive Its Revenue Growth?

The pharmaceutical lipid-based excipients market covered in this report is segmented –

1) By Excipient Type: Oils, Hydrogenated Vegetable Oils, GMCC, Hard Fats, Medium Chain Triglycerides, Lecithin And Phospholipids, Sodium Oleate, Capri Caprylic Mono Diglyceride, Other Excipient Types

2) By Product Applications: Oral Formulations, Parenteral, Topical Applications, Ophthalmic Applications, Suppositories, Other Product Applications

3) By Disease Application: Cardiovascular Diseases, Neurological Disorders, Oncology, Metabolic Disorders, Hormonal Therapies, Infectious Diseases, Other Disease Applications

4) By Age Group: Pediatric Products (0-18 years), Adult Products (19-64 years), Geriatric Products (65+ years)

5) By End-Use: Pharmaceutical Manufacturers, Contract Development And Manufacturing Organizations, Other End Users

Subsegments:

1) By Oils: Soybean Oil, Olive Oil, Palm Oil, Sunflower Oil, Other Oils

2) By Hydrogenated Vegetable Oils: Hydrogenated Soybean Oil, Hydrogenated Palm Oil, Hydrogenated Cottonseed Oil, Other Hydrogenated Vegetable Oils

3) By GMCC (Glyceryl Mono/Diesters of C16/C18): Glyceryl Monostearate, Glyceryl Distearate, Glyceryl Monopalmitate, Other GMCC

4) By Hard Fats: Hydrogenated Castor Oil, Hydrogenated Palm Kernel Oil, Hydrogenated Coconut Oil, Other Hard Fats

5) By Medium Chain Triglycerides (MCTs): Capric Triglycerides, Caprylic Triglycerides, Caprylic-Capric Triglycerides, Other MCTs

6) By Lecithin and Phospholipids: Soy Lecithin, Egg Lecithin, Phosphatidylcholine, Phosphatidylserine, Other Lecithin and Phospholipids

7) By Sodium Oleate: Pharmaceutical Grade Sodium Oleate, Food Grade Sodium Oleate, Industrial Grade Sodium Oleate

8) By Capri-Caprylic Mono/Diglycerides: Capric-Caprylic Monoglycerides, Capric-Caprylic Diglycerides

9) By Other Excipient Types: Sucrose Esters, Fatty Acid Esters, PEGylated Lipids, Other Miscellaneous Lipids

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=24374&type=smp

Which Areas Are Leading Regions in the Pharmaceutical Lipid-Based Excipients Market Expansion Across the Globe?

Europe was the largest region in the pharmaceutical lipid-based excipients market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical lipid-based excipients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Technological Trends Are Reshaping the Pharmaceutical Lipid-Based Excipients Industry Dynamics?

Major pharmaceutical lipid-based excipients market players are emphasizing on strategic investment opportunities such as the development of an innovative Center of Excellence. This center’s purpose is to fuel innovation, intensify formulation competencies, back drug delivery research, and solidify their market standing in new therapeutic sectors. For example, Gattefossé SAS, a France-based chemical manufacturer, inaugurated an advanced Technical Center of Excellence in Mumbai in November 2024. Aimed at supporting India’s expanding pharmaceutical market, this center offers bespoke labs and targeted support for excipient innovation. It particularly focuses on bioavailability, sustained release, and topical formulations and helps fortify its reach in the Asia-Pacific circuit. The modern facility comprises pharmaceutical and personal care application labs to boost innovation, facilitate teamwork, and generate a conducive work atmosphere.

View the full report here:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-lipid-based-excipients-global-market-report

How Is the Pharmaceutical Lipid-Based Excipients Market Conceptually Defined?

Pharmaceutical lipid-based excipients are non-active (inactive) substances derived from lipids used in drug formulations to help deliver, stabilize, or enhance the absorption of the active pharmaceutical ingredient (API). Pharmaceutical lipid-based excipients aim to improve drug solubility, stability, and bioavailability, particularly for poorly water-soluble drugs.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24374

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

We’ve updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

What Are the Projected Market Size and Growth Rates for the Pharmaceutical Lipid-Based Excipients Market From 2025 To 2029?

In recent times, there has been substantial growth in the size of the pharmaceutical lipid-based excipients market. The market, which was valued at $1.69 billion in 2024, is projected to expand to $1.79 billion in 2025, with a compound annual growth rate (CAGR) of 5.8%. The surge during the historical period can be linked to several factors such as the rise of drugs that are poorly soluble in water, the growing demand for targeted and controlled drug release, increasing investments in the pharmaceutical sector, the widespread usage of oral solid dosage forms, a heightened emphasis on enhancing drug bioavailability, and the regulatory approval of lipid excipients in novel formulations.

In the coming years, the market size for pharmaceutical lipid-based excipients is anticipated to witness significant expansion. The projection is for it to reach $2.22 billion in 2029, with a compound annual growth rate (CAGR) of 5.5%. Several factors could contribute to growth during the projected period such as an increased demand for cutting-edge drug delivery systems, rising usage of mRNA and gene therapies, swelling pipeline for drugs with poor water solubility, a heightened emphasis on individualized medicine, beneficial regulatory oversight, and strategic capital injections in biopharmaceutical manufacturing infrastructure. Noteworthy trends throughout this period include advancements in lipid nanoparticle delivery systems, the embracement of mRNA and gene therapies, upgraded solubility solutions for poorly water-soluble drugs, the broadening of biocompatible and eco-friendly lipid sources, improved manufacturing scalability, and wider usage in oral and injectable formulations.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24374&type=smp

Which Primay Drivers Are Accelerating Growth in the Pharmaceutical Lipid-Based Excipients Market?

The growth of the pharmaceutical lipid-based excipients market is anticipated to be driven by the advancement in gene therapy. Gene therapy is a cutting-edge medical approach that manipulates or alters a person’s genes to battle or avert illnesses. The surge in popularity of gene therapy is primarily due to the progress of delivery systems that guarantee safe, efficient, and focused transportation of genetic materials into cells. Pharmaceutical lipid-based excipients play a crucial role in improving gene therapy as they facilitate efficient delivery systems, ensure stability and maintain targeted transport of genetic materials. The therapeutic outcomes are improved as these excipients protect nucleic acids and boost cellular uptake, thereby enhancing the potency of contemporary treatments. For example, in December 2024, the American Society of Gene & Cell Therapy (ASGCT), a notable non-profit medical and scientific organization in the United States, noted that the Food and Drug Administration (FDA) has increased gene therapy product approvals from five in 2022 to six in 2023. Consequently, the pharmaceutical lipid-based excipients market’s growth is propelled by the expansion in gene therapy.

Which Primary Segments of the Pharmaceutical Lipid-Based Excipients Market Are Driving Growth and Industry Transformations?

The pharmaceutical lipid-based excipients market covered in this report is segmented –

1) By Excipient Type: Oils, Hydrogenated Vegetable Oils, GMCC, Hard Fats, Medium Chain Triglycerides, Lecithin And Phospholipids, Sodium Oleate, Capri Caprylic Mono Diglyceride, Other Excipient Types

2) By Product Applications: Oral Formulations, Parenteral, Topical Applications, Ophthalmic Applications, Suppositories, Other Product Applications

3) By Disease Application: Cardiovascular Diseases, Neurological Disorders, Oncology, Metabolic Disorders, Hormonal Therapies, Infectious Diseases, Other Disease Applications

4) By Age Group: Pediatric Products (0-18 years), Adult Products (19-64 years), Geriatric Products (65+ years)

5) By End-Use: Pharmaceutical Manufacturers, Contract Development And Manufacturing Organizations, Other End Users

Subsegments:

1) By Oils: Soybean Oil, Olive Oil, Palm Oil, Sunflower Oil, Other Oils

2) By Hydrogenated Vegetable Oils: Hydrogenated Soybean Oil, Hydrogenated Palm Oil, Hydrogenated Cottonseed Oil, Other Hydrogenated Vegetable Oils

3) By GMCC (Glyceryl Mono/Diesters of C16/C18): Glyceryl Monostearate, Glyceryl Distearate, Glyceryl Monopalmitate, Other GMCC

4) By Hard Fats: Hydrogenated Castor Oil, Hydrogenated Palm Kernel Oil, Hydrogenated Coconut Oil, Other Hard Fats

5) By Medium Chain Triglycerides (MCTs): Capric Triglycerides, Caprylic Triglycerides, Caprylic-Capric Triglycerides, Other MCTs

6) By Lecithin and Phospholipids: Soy Lecithin, Egg Lecithin, Phosphatidylcholine, Phosphatidylserine, Other Lecithin and Phospholipids

7) By Sodium Oleate: Pharmaceutical Grade Sodium Oleate, Food Grade Sodium Oleate, Industrial Grade Sodium Oleate

8) By Capri-Caprylic Mono/Diglycerides: Capric-Caprylic Monoglycerides, Capric-Caprylic Diglycerides

9) By Other Excipient Types: Sucrose Esters, Fatty Acid Esters, PEGylated Lipids, Other Miscellaneous Lipids

Request customized data on this market:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24374&type=smp

Which Regions Are Key Players in the Growth of the Pharmaceutical Lipid-Based Excipients Market?

Europe was the largest region in the pharmaceutical lipid-based excipients market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical lipid-based excipients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Technological Trends Are Reshaping the Pharmaceutical Lipid-Based Excipients Industry Dynamics?

Major pharmaceutical lipid-based excipients market players are prioritizing strategic investments aimed at establishing cutting-edge Centers of Excellence to propel innovation, augment formulary skills, back drug delivery research, and boost their competitive edge in burgeoning therapeutic fields. A case in point is Gattefossé SAS, a chemical manufacturing firm from France. In November 2024, the company opened a state-of-the-art Technical Center of Excellence in Mumbai, India, aiming to support the escalating pharma market in the country. The center offers dedicated labs and personalized assistance for excipient innovation, concentrating on bioavailability, sustained release, and topical formulations, thereby fortifying its footprint in the Asia-Pacific market. This ultra-modern facility features pharmaceutical and personal care application labs designed to stimulate innovation, promote teamwork, and offer a conducive working atmosphere.

View the full report here:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-lipid-based-excipients-global-market-report

What Parameters Are Used to Define the Pharmaceutical Lipid-Based Excipients Market?

Pharmaceutical lipid-based excipients are non-active (inactive) substances derived from lipids used in drug formulations to help deliver, stabilize, or enhance the absorption of the active pharmaceutical ingredient (API). Pharmaceutical lipid-based excipients aim to improve drug solubility, stability, and bioavailability, particularly for poorly water-soluble drugs.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/customise?id=24374&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model